Bottom line
What is CHCLX's expense ratio?
CHCLX's expense ratio is 0.92%, or about $92 a year on every $10,000 invested. That is more expensive than 56% of large growth funds we track (median 0.87%). This share class also charges a front-end sales load of up to 4.25%, taken from your investment when you buy. Its expense ratio includes a 0.23% 12b-1 marketing fee.
Updated Oct 28, 2026
CHCLX fee table
| Net expense ratio | 0.92% |
|---|---|
| Gross expense ratio | 0.93% |
| Management fee | 0.61% |
| 12b-1 (distribution) fee | 0.23% |
| Other expenses | 0.08% |
| Acquired fund fees | 0.01% |
| Fee waiver / reimbursement | -0.01% |
| Max front-end sales load | 4.25% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Oct 28, 2026
What CHCLX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| CHCLX | $515 | $708 | $917 | $1,519 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.92% expense ratio costs roughly $51,300 in lost growth, versus about $48,700 for the median large growth fund (0.87%).